Accessed Feb 5, 2026 at FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
What the Guidelines Say About Magnesium in Diabetes Management The 2024 ADA Standards of Medical Care in Diabetes state: "Routine supplementation with antioxidants, such as vitamins E and C, and carotene is not advised due to lack of evidence of efficacy and concern related to long-term safety
Understanding Semaglutide and Its Uses Semaglutide is a GLP-1 receptor agonist that helps manage: Type 2 diabetes (Ozempic, Rybelsus) Obesity and overweight with related health conditions (Wegovy) Semaglutide is FDA-approved for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management in individuals with obesity or overweight with related conditions (Wegovy)
Once at a therapeutic maintenance dose, this may increase to 4 to 8 pounds, though individual results vary
Older adults may be at higher risk because age-related muscle loss can already be present before treatment begins
